Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-08-14 00:00:00 ET · period of report 2023-08-10 · accession 0000899243-23-018113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-14 | 2023-08-10 | VRTX | Kearney Terrence C | Dir | M - OptEx | $127.54 | +10.0K | 16.5K | +153% | +$1.28M |
| D | 2023-08-14 | 2023-08-10 | VRTX | Kearney Terrence C | Dir | S - Sale+OE | $350.00 | -10.0K | 6,536 | -60% | -$3.50M |
| D | 2023-08-14 | 2023-08-10 | VRTX | Kearney Terrence C | Dir | M - OptEx | $0.00 | -10.0K | 10.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-10 | M | A | 10,000 | $127.54 | 16,536 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-10 | S | D | 10,000 | $350.00 | 6,536 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-08-10 | M | D | 10,000 | $0.00 | 10,000 | D | $127.54 · — to 2025-05-31 | 10,000 Common Stock | (F2) Fully vested. |